STOCK TITAN

Vera Therapeutics: Avoro reports 7.82% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Vera Therapeutics, Inc. (VERA) Schedule 13G/A reports that Avoro Capital Advisors LLC and Behzad Aghazadeh each beneficially own 5,635,000 shares of Class A common stock, or 7.82% of the class. Both report sole voting and dispositive power over the shares, with no shared voting or dispositive power.

Avoro acquired the shares solely for investment on behalf of Avoro Life Sciences Fund LLC. Aghazadeh serves as Avoro’s portfolio manager and controlling person. The reported percentage is based on 72,063,335 shares outstanding as of July 29, 2026.

Beneficially owned shares 5,635,000 shares Avoro Capital Advisors LLC and Behzad Aghazadeh each report this amount; it is not a combined total.
Ownership percentage 7.82% Reported by each reporting person.
Class A shares outstanding 72,063,335 shares As of July 29, 2026; used to calculate the reported ownership percentage.
beneficial ownership regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole voting power regulatory
"Sole Voting Power 5,635,000.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power regulatory
"Sole Dispositive Power 5,635,000.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VERA shares do Avoro Capital Advisors and Behzad Aghazadeh report owning?

Each reports beneficial ownership of 5,635,000 shares of Vera Therapeutics Class A common stock, equal to 7.82% of the class. The percentage is based on 72,063,335 shares outstanding as of July 29, 2026.

Who receives dividends or sale proceeds from Avoro’s VERA holdings?

Avoro Life Sciences Fund LLC has the right to receive or direct dividends from, or proceeds from the sale of, more than 5% of Vera Therapeutics’ Class A common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





92337R101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Avoro Capital Advisors LLC
Signature:/s/ Scott Epstein
Name/Title:Scott Epstein, Chief Operating Officer & Chief Compliance Officer
Date:11/16/2026
Behzad Aghazadeh
Signature:/s/ Behzad Aghazadeh
Name/Title:Behzad Aghazadeh, Individually
Date:11/16/2026

Keep reading